GordonMD Global Investments LP
CIK: 0002039349
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PYXS
Pyxis Oncology, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About GordonMD Global Investments LP
GordonMD Global Investments LP (SEC CIK 0002039349) files insider reports with the SEC as 10% Owner of Pyxis Oncology, Inc. (PYXS).
Signal8 holds 3 ownership filings by GordonMD Global Investments LP (1 Form 3, 2 Form 4), filed between Jul 10, 2026 and Oct 9, 2026. Those filings report 2 transactions, the latest on Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on GordonMD Global Investments LP's filings is in BEVERELY HILLS, CA.
Recent filings by GordonMD Global Investments LP
- Oct 1, 2026: Open-market purchases of PYXS derivative securities (2 lines, Form 4, code P).
Other insiders filing for Pyxis Oncology, Inc. (PYXS)
- Civik Thomas, CEO & Chairman of the Board
- Dupont Jakob, Director
- Wadhane Jitendra, Prin Fin & Acct Officer
- FLAVIN JOHN L, Director
- Metzger Michael A, Director
- Lewis-Hall Freda C, Director